HRP20010885B1 - Ethanesulfonyl-piperidine derivatives - Google Patents
Ethanesulfonyl-piperidine derivativesInfo
- Publication number
- HRP20010885B1 HRP20010885B1 HR20010885A HRP20010885A HRP20010885B1 HR P20010885 B1 HRP20010885 B1 HR P20010885B1 HR 20010885 A HR20010885 A HR 20010885A HR P20010885 A HRP20010885 A HR P20010885A HR P20010885 B1 HRP20010885 B1 HR P20010885B1
- Authority
- HR
- Croatia
- Prior art keywords
- ethanesulfonyl
- piperidine derivatives
- denotes
- denotes hydrogen
- hydroxy
- Prior art date
Links
- GZJHPGLSIOWQJE-UHFFFAOYSA-N 1-ethylsulfonylpiperidine Chemical class CCS(=O)(=O)N1CCCCC1 GZJHPGLSIOWQJE-UHFFFAOYSA-N 0.000 title 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/54—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/42—Oxygen atoms attached in position 3 or 5
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99111126 | 1999-06-08 | ||
PCT/EP2000/004953 WO2000075109A1 (en) | 1999-06-08 | 2000-05-31 | Ethanesulfonyl-piperidine derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
HRP20010885A2 HRP20010885A2 (en) | 2004-02-29 |
HRP20010885B1 true HRP20010885B1 (en) | 2010-07-31 |
Family
ID=8238316
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR20010885A HRP20010885B1 (en) | 1999-06-08 | 2001-11-28 | Ethanesulfonyl-piperidine derivatives |
Country Status (38)
Country | Link |
---|---|
US (1) | US6310213B1 (ko) |
EP (1) | EP1189886B1 (ko) |
JP (1) | JP3645856B2 (ko) |
KR (1) | KR100571162B1 (ko) |
CN (1) | CN1142141C (ko) |
AR (1) | AR024282A1 (ko) |
AT (1) | ATE315025T1 (ko) |
AU (1) | AU770787B2 (ko) |
BR (1) | BR0011419A (ko) |
CA (1) | CA2376091C (ko) |
CO (1) | CO5160328A1 (ko) |
CZ (1) | CZ299483B6 (ko) |
DE (1) | DE60025348T2 (ko) |
DK (1) | DK1189886T3 (ko) |
EG (1) | EG26101A (ko) |
ES (1) | ES2254183T3 (ko) |
GC (1) | GC0000256A (ko) |
GT (1) | GT200000089A (ko) |
HK (1) | HK1046412B (ko) |
HR (1) | HRP20010885B1 (ko) |
HU (1) | HU228591B1 (ko) |
IL (2) | IL146750A0 (ko) |
JO (1) | JO2260B1 (ko) |
MA (1) | MA26797A1 (ko) |
MX (1) | MXPA01012585A (ko) |
MY (1) | MY128818A (ko) |
NO (1) | NO320613B1 (ko) |
PA (1) | PA8496601A1 (ko) |
PE (1) | PE20010218A1 (ko) |
PL (1) | PL196053B1 (ko) |
RS (1) | RS50033B (ko) |
RU (1) | RU2242464C2 (ko) |
SI (1) | SI1189886T1 (ko) |
TN (1) | TNSN00125A1 (ko) |
TR (1) | TR200103532T2 (ko) |
TW (1) | TWI254043B (ko) |
WO (1) | WO2000075109A1 (ko) |
ZA (1) | ZA200109706B (ko) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE273953T1 (de) * | 2000-03-22 | 2004-09-15 | Hoffmann La Roche | Piperidin- und pirazinverbindungen zur verwendung in der behandlung von alzheimer |
ES2225553T3 (es) | 2000-04-20 | 2005-03-16 | F. Hoffmann-La Roche Ag | Derivados de pirrolidina y piperidina y su empleo para el tratamiento de trastornos neurodegenerativos. |
US6407235B1 (en) | 2000-08-21 | 2002-06-18 | Hoffmann-La Roche Inc. | Prodrug acid esters of [2-(4-benzyl-3-hydroxy-piperidin-1-yl)-ethansulfonyl]phenol |
EP1332363A4 (en) * | 2000-10-09 | 2007-08-29 | Kay Double | PROOF OF NEURODEGENERATIVE DISEASES |
US6951875B2 (en) * | 2001-10-29 | 2005-10-04 | Hoffmann-La Roche Inc. | Conjugated aromatic compounds with a pyridine substituent |
US7005432B2 (en) * | 2002-05-16 | 2006-02-28 | Hoffman-La Roche Inc. | Substituted imidazol-pyridazine derivatives |
WO2009118187A1 (en) * | 2008-03-27 | 2009-10-01 | Evotec Neurosciences Gmbh | Methods for treating disorders using nmda nr2b-subtype selective antagonist |
US20150045556A1 (en) * | 2011-07-18 | 2015-02-12 | Roland E. Dolle | Processes for the preparation of peripheral opioid antagonist compounds and intermediates thereto |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995025721A1 (de) * | 1994-03-24 | 1995-09-28 | Schering Aktiengesellschaft | Neue 1,4-disubstituierte piperidin-derivate als auf den glutamat-rezeptor wirkende arzneimittel |
WO1997023216A1 (en) * | 1995-12-22 | 1997-07-03 | Warner-Lambert Company | 4-substituted piperidine analogs and their use as subtype selective nmda receptor antagonists |
EP0824098A1 (en) * | 1996-07-19 | 1998-02-18 | F. Hoffmann-La Roche Ag | 4-hydroxy-piperidine derivatives |
-
2000
- 2000-05-24 TW TW089109992A patent/TWI254043B/zh not_active IP Right Cessation
- 2000-05-31 BR BR0011419-7A patent/BR0011419A/pt not_active Application Discontinuation
- 2000-05-31 JP JP2001501590A patent/JP3645856B2/ja not_active Expired - Fee Related
- 2000-05-31 CA CA002376091A patent/CA2376091C/en not_active Expired - Fee Related
- 2000-05-31 KR KR1020017015765A patent/KR100571162B1/ko not_active IP Right Cessation
- 2000-05-31 CZ CZ20014349A patent/CZ299483B6/cs not_active IP Right Cessation
- 2000-05-31 ES ES00936835T patent/ES2254183T3/es not_active Expired - Lifetime
- 2000-05-31 SI SI200030793T patent/SI1189886T1/sl unknown
- 2000-05-31 WO PCT/EP2000/004953 patent/WO2000075109A1/en active IP Right Grant
- 2000-05-31 DE DE60025348T patent/DE60025348T2/de not_active Expired - Lifetime
- 2000-05-31 RU RU2001135806/04A patent/RU2242464C2/ru not_active IP Right Cessation
- 2000-05-31 AU AU52181/00A patent/AU770787B2/en not_active Ceased
- 2000-05-31 CN CNB008086028A patent/CN1142141C/zh not_active Expired - Fee Related
- 2000-05-31 DK DK00936835T patent/DK1189886T3/da active
- 2000-05-31 PL PL00352723A patent/PL196053B1/pl unknown
- 2000-05-31 IL IL14675000A patent/IL146750A0/xx active IP Right Grant
- 2000-05-31 TR TR2001/03532T patent/TR200103532T2/xx unknown
- 2000-05-31 RS YUP-865/01A patent/RS50033B/sr unknown
- 2000-05-31 AT AT00936835T patent/ATE315025T1/de active
- 2000-05-31 EP EP00936835A patent/EP1189886B1/en not_active Expired - Lifetime
- 2000-05-31 HU HU0201916A patent/HU228591B1/hu not_active IP Right Cessation
- 2000-05-31 MX MXPA01012585A patent/MXPA01012585A/es active IP Right Grant
- 2000-06-02 US US09/585,755 patent/US6310213B1/en not_active Expired - Lifetime
- 2000-06-02 PE PE2000000547A patent/PE20010218A1/es not_active Application Discontinuation
- 2000-06-03 TN TNTNSN00125A patent/TNSN00125A1/fr unknown
- 2000-06-05 EG EG2000060739A patent/EG26101A/en active
- 2000-06-05 AR ARP000102775A patent/AR024282A1/es active IP Right Grant
- 2000-06-05 PA PA20008496601A patent/PA8496601A1/es unknown
- 2000-06-06 MY MYPI20002522A patent/MY128818A/en unknown
- 2000-06-07 GC GCP2000702 patent/GC0000256A/en active
- 2000-06-07 JO JO200087A patent/JO2260B1/en active
- 2000-06-07 CO CO00042340A patent/CO5160328A1/es unknown
- 2000-06-07 GT GT200000089A patent/GT200000089A/es unknown
-
2001
- 2001-11-26 IL IL146750A patent/IL146750A/en not_active IP Right Cessation
- 2001-11-26 ZA ZA200109706A patent/ZA200109706B/en unknown
- 2001-11-28 HR HR20010885A patent/HRP20010885B1/xx not_active IP Right Cessation
- 2001-12-04 NO NO20015920A patent/NO320613B1/no not_active IP Right Cessation
- 2001-12-07 MA MA26438A patent/MA26797A1/fr unknown
-
2002
- 2002-11-05 HK HK02108022.3A patent/HK1046412B/zh not_active IP Right Cessation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995025721A1 (de) * | 1994-03-24 | 1995-09-28 | Schering Aktiengesellschaft | Neue 1,4-disubstituierte piperidin-derivate als auf den glutamat-rezeptor wirkende arzneimittel |
WO1997023216A1 (en) * | 1995-12-22 | 1997-07-03 | Warner-Lambert Company | 4-substituted piperidine analogs and their use as subtype selective nmda receptor antagonists |
EP0824098A1 (en) * | 1996-07-19 | 1998-02-18 | F. Hoffmann-La Roche Ag | 4-hydroxy-piperidine derivatives |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR200200579T2 (tr) | Amino-tirazolpiridin türevleri. | |
GB9801690D0 (en) | Therapeutic agents | |
BG106586A (en) | Pyrazolopyramidines as therapeutic agents | |
YU69902A (sh) | Novi derivati piperazina | |
RS50140B (sr) | Postupak za dobijanje perkihinina i njegova upotreba | |
RS49688B (sr) | Novi derivat 3-aril-2- hidroksipropionske kiseline (i) | |
BG106585A (en) | Kinase inhibitors as therapeutic agents | |
NO950297L (no) | Prolinamidderivater | |
CO5031285A1 (es) | Triarilimidazoles | |
ATE297203T1 (de) | Antithrombotische mitteln | |
PT1109812E (pt) | Pirrolobenzodiazepinas | |
BG103310A (en) | Benzonaphthyridins as bronchial therapeutical means | |
MXPA03002911A (es) | Compuestos quimicos. | |
AU2001266575A1 (en) | Chemical compounds | |
MXPA02012076A (es) | Compuestos quimicos. | |
RS50229B (sr) | Analozi vitamina d3 | |
WO2000005214A3 (en) | Isoquinolines as urokinase inhibitors | |
HK1045990A1 (en) | Novel derivatives and analogues of galanthamin. | |
YU30603A (sh) | Derivati premošćenog piperazina | |
TR200201128T2 (tr) | PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri. | |
TR200001452T2 (tr) | Bifenilamidin türevleri. | |
DE60112960D1 (de) | Kondensierte pyridoindolderivate | |
CA2412596A1 (en) | Cyclic gmp-specific phosphodiesterase inhibitors | |
TR200001909T2 (tr) | Matris metaloprotez inhibitörleri. | |
DK1204658T3 (da) | Benzofurylpiperazin-serotoninagonister |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A1OB | Publication of a patent application | ||
ARAI | Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application | ||
B1PR | Patent granted | ||
PPPP | Transfer of rights |
Owner name: EVOTEC INTERNATIONAL GMBH, DE |
|
ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20140522 Year of fee payment: 15 |
|
PBON | Lapse due to non-payment of renewal fee |
Effective date: 20150531 |